|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500096200 |
|
最近更新日期: Date of Last Refreshed on: |
2025-01-20 15:36:00 |
|
注册时间: Date of Registration: |
2025-01-20 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
高血压/2型糖尿病患者健康生活方式与临床结局:中国北方四省多中心前瞻性队列研究 |
|
Public title: |
Healthy lifestyle and clinical outcomes in patients with hypertension / type 2 diabetes : a multicenter prospective cohort study in four provinces of northern China |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
高血压/2型糖尿病患者健康生活方式与临床结局:中国北方四省多中心前瞻性队列研究 |
|
Scientific title: |
Healthy lifestyle and clinical outcomes in patients with hypertension / type 2 diabetes : a multicenter prospective cohort study in four provinces of northern China |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
冯宜飞 |
研究负责人: |
苗豫东 |
|
Applicant: |
Yifei Feng |
Study leader: |
Yudong Miao |
|
申请注册联系人电话: Applicant telephone: |
+86 181 3737 0425 |
研究负责人电话: Study leader's telephone: |
+86 139 3902 6699 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
fengyifei2019@163.com |
研究负责人电子邮件: Study leader's E-mail: |
meldon@zzu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
河南省郑州市高新区科学大道100号郑州大学公共卫生学院 |
研究负责人通讯地址: |
河南省郑州市高新区科学大道100号郑州大学公共卫生学院 |
|
Applicant address: |
College of Public Health, Zhengzhou University, 100 Science Avenue, Zhengzhou High-tech Zone, Henan Province |
Study leader's address: |
College of Public Health, Zhengzhou University, 100 Science Avenue, Zhengzhou High-tech Zone, Henan Province |
|
申请注册联系人邮政编码: Applicant postcode: |
450001 |
研究负责人邮政编码: Study leader's postcode: |
450001 |
|
申请人所在单位: |
郑州大学 |
||
|
Applicant's institution: |
Zhengzhou University |
||
|
研究负责人所在单位: |
郑州大学 |
||
|
Affiliation of the Leader: |
Zhengzhou University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
ZZUIRB2023-318 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
郑州大学生命科学伦理审查委员会 |
||
|
Name of the ethic committee: |
Life Science Ethics Review Committee of Zhengzhou University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-12-14 00:00:00 |
||
|
伦理委员会联系人: |
夏老师 |
||
|
Contact Name of the ethic committee: |
Miss Xia |
||
|
伦理委员会联系地址: |
郑州市科学大道100号郑州大学综合管理中心426房间 |
||
|
Contact Address of the ethic committee: |
Room 426, Comprehensive Management Center, Zhengzhou University, 100 Kexue Road, Gaoxin district, Zhengzhou |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 181 1856 8691 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
郑州大学 |
||||||||||||||||||||||
|
Primary sponsor: |
Zhengzhou University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
河南省郑州市高新区科学大道100号郑州大学公共卫生学院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
College of Public Health, Zhengzhou University, 100 Science Avenue, Zhengzhou High-tech Zone, Henan Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
(1)国家自然科学基金青年项目:基于交易费用理论的医院-社区慢性病医疗服务协作制度优化研究(编号:71603132) (2)国家社科基金面上项目:整合型医疗卫生服务体系交易费用测度与应对策略研究(编号:21BGL222) (3)国家重点研发:面向贫困地区的远程、移动、智慧医疗一体化服务联合体数字诊疗装备配置解决方案研究(编号:2018YFC0114501)、 (4)国家基本公共卫生服务项目重点人群(老年人、高血压和2型糖尿病)健康体检 (5)郑州大学科研创新项目:新冠肺炎强化疫苗接种率预测模型构建与仿真(编号:20211207) |
||||||||||||||||||||||
|
Source(s) of funding: |
( 1 ) National Natural Science Foundation of China Youth Project : Research on the Optimization of Hospital-Community Chronic Disease Medical Service Cooperation System Based on Transaction Cost Theory ( No.71603132 ) ( 2 ) National Social Science Fund Project : Research on transaction cost measurement and coping strategies of integrated medical and health service system ( No.21BGL222 ) ( 3 ) National key research and development : research on digital diagnosis and treatment equipment configuration solution for remote, mobile and intelligent medical integration service consortium for poverty-stricken areas ( No. 2018YFC0114501 ), ( 4 ) Health examination of the key population ( the elderly, hypertension and type 2 diabetes ) of the national basic public health service project ( 5 ) Scientific research and innovation project of Zhengzhou University : Construction and simulation of prediction model for coverage rate of COVID-19 booster vaccine ( No.20211207 ) |
||||||||||||||||||||||
|
Target disease: |
Cognitive function and cardiovascular disease |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
(1)建设生活方式医学队列,建立基于问卷调查数据和国家基本公共卫生服务数据融合的大数据库; (2)通过大数据分析技术量化多种健康生活方式在改善慢性病人群临床结局和社会功能中的作用机制; (3)以生活方式干预结合最小限度临床用药为手段,研制经济、有效的生活方式医学临床干预应用指南; (4)结合信息技术驱动实现“指南”临床规模化应用,创建“两病”防控新范式; (5)建设国内首个“两病”数智化健康生活方式医学干预示范。 |
||||||||||||||||||||||
|
Objectives of Study: |
( 1 ) Establish a lifestyle medicine cohort and a large database based on the integration of questionnaire survey data and national basic public health service data; ( 2 ) To quantify the mechanism of various healthy lifestyles in improving clinical outcomes and social function of chronic disease population through big data analysis technology; ( 3 ) To develop an economical and effective clinical intervention application guide for lifestyle medicine by means of lifestyle intervention combined with minimal clinical medication; ( 4 ) Combined with information technology driven to realize the clinical scale application of 'guideline', and create a new paradigm for the prevention and control of 'two diseases'; ( 5 ) Construction of the first domestic 'two diseases' digital intelligent healthy lifestyle medical intervention demonstration. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)纳入国家基本公共卫生服务的高血压/糖尿病人群; (2)年龄≥65岁; (3)国家基本公共卫生服务数据库体检数据完整; (4)同意参加本研究,并签署知情同意书。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) hypertension / diabetes population included in the national basic public health services ; (2) age >= 65 years ; (3)The physical examination data of the national basic public health service database is complete ; (4) Agree to participate in this study and sign the informed consent. |
||||||||||||||||||||||
|
排除标准: |
(1)孕妇、有精神疾病、痴呆以及艾滋病患者; (2)继发性高血压、1型糖尿病患者; (3)失能或严重伤残者; (4)各种原因无法完成问卷调查、血标本收集和体格检查者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1)pregnant women, patients with mental illness, dementia and AIDS ; (2) patients with secondary hypertension and type 1 diabetes ; (3)Disabled or severely disabled ; (4)Those who cannot complete the questionnaire survey, blood sample collection and physical examination for various reasons. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-03-06 00:00:00至 To 2028-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2023-07-01 00:00:00 至 To 2024-03-08 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
发表文章后;www.medresman.org |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
After publishing the paper; www.medresman.org |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
EDC |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |